REQUEST A DEMO
Total
USD $0.00
Search more companies

Fagofarma S.R.O. (Czech Republic)

Main Activities: Pharmaceutical and Medicine Manufacturing | Medicinal and Botanical Manufacturing
Full name: Fagofarma S.R.O. Profile Updated: June 01, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Fagofarma S.R.O. is an enterprise located in Czech Republic, with the main office in Prague. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on September 23, 2013. 25 - 49 (2024) employees currently work for Fagofarma S.R.O.. From the latest financial highlights, Fagofarma S.R.O. reported a net sales revenue increase of 24.15% in 2025. Its’ total assets recorded a growth of 84.35%. The net profit margin of Fagofarma S.R.O. decreased by 1.12% in 2025.

Headquarters
Londynska 730/59
Prague; The City of Prague; Postal Code: 12000

Contact Details: Purchase the Fagofarma S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Fagofarma S.R.O. report to view the information.
Registered Capital:
Purchase the Fagofarma S.R.O. report to view the information.
Financial Auditors:
Purchase the Fagofarma S.R.O. report to view the information.
Incorporation Date:
September 23, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Fagofarma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
24.15%
Total Operating Revenue
28.93%
Operating Profit
13.64%
EBITDA
-2.1%
Net Profit/Loss for the Period
6.62%
Total Assets
84.35%
Total Equity
52.05%
Operating Profit Margin
-0.81%
Net Profit Margin
-1.12%
Return on Equity (ROE)
-14.59%
Debt / Equity
26.6%
Quick Ratio
-0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?